Oral S-adenosylmethionine in primary fibromyalgia. Double-blind clinical evaluation.

S-adenosylmethionine is a relatively new anti-inflammatory drug with analgesic and anti-depressant effects. Efficacy of 800 mg orally administered s-adenosylmethionine daily versus placebo for six weeks was investigated in 44 patients with primary fibromyalgia in double-blind settings. Tender point score, isokinetic muscle strength, disease activity, subjective symptoms (visual analog scale), mood parameters and side effects were evaluated. Improvements were seen for clinical disease activity (P = 0.04), pain experienced during the last week (P = 0.002), fatigue (P = 0.02), morning stiffness (P = 0.03) and mood evaluated by Face Scale (P = 0.006) in the actively treated group compared to placebo. The tender point score, isokinetic muscle strength, mood evaluated by Beck Depression Inventory and side effects did not differ in the two treatment groups. S-adenosylmethionine has some beneficial effects on primary fibromyalgia and could be an important option in the treatment hereof.

[1]  B. Danneskiold-Samsøe,et al.  Inter-relations between clinical parameters and muscle function in patients with primary fibromyalgia. , 1989, Clinical and experimental rheumatology.

[2]  A. Goldberg,et al.  Fenofibrate affects the compositions of lipoproteins. , 1987, The American journal of medicine.

[3]  A. Maccagno,et al.  Double-blind controlled clinical trial of oral S-adenosylmethionine versus piroxicam in knee osteoarthritis. , 1987, The American journal of medicine.

[4]  G. Vetter.  Double-blind comparative clinical trial with S-adenosylmethionine and indomethacin in the treatment of osteoarthritis. , 1987, The American journal of medicine.

[5]  B. König,et al.  A long-term (two years) clinical trial with S-adenosylmethionine for the treatment of osteoarthritis. , 1987, The American journal of medicine.

[6]  I. Caruso,et al.  Italian double-blind multicenter study comparing S-adenosylmethionine, naproxen, and placebo in the treatment of degenerative joint disease. , 1987, The American journal of medicine.

[7]  C. Padova.  S-Adenosylmethionine in the treatment of osteoarthritis: Review of the clinical studies , 1987 .

[8]  G. Stramentinoli,et al.  Pharmacologic aspects of S-adenosylmethionine. Pharmacokinetics and pharmacodynamics. , 1987, The American journal of medicine.

[9]  B. Toone,et al.  S-adenosylmethionine and affective disorder. , 1987, The American journal of medicine.

[10]  H. Müller-Fassbender.  Double-blind clinical trial of S-adenosylmethionine versus ibuprofen in the treatment of osteoarthritis. , 1987, The American journal of medicine.

[11]  G. Pasero,et al.  Evaluation of s-adenosylmethionine in primary fibromyalgia: A double-blind crossover study , 1987 .

[12]  C. Lorish,et al.  The Face Scale: a brief, nonverbal method for assessing patient mood. , 1986, Arthritis and rheumatism.

[13]  F. Wolfe,et al.  Fibrositis: symptom frequency and criteria for diagnosis. An evaluation of 291 rheumatic disease patients and 58 normal individuals. , 1985, The Journal of rheumatology.

[14]  M. Yunus,et al.  Psychological factors associated with primary fibromyalgia syndrome. , 1984, Arthritis and rheumatism.

[15]  F. Wolfe,et al.  Prevalence of primary and secondary fibrositis. , 1983, The Journal of rheumatology.

[16]  F. Berti,et al.  Anti-inflammatory activity of S-adenosyl-L-methionine: interference with the eicosanoid system. , 1983, Pharmacological research communications.

[17]  A. Bohan.  The private practice of rheumatology. The first 1,000 patients. , 1981, Arthritis and rheumatism.

[18]  M. Yunus,et al.  Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. , 1981, Seminars in arthritis and rheumatism.

[19]  H. Moldofsky,et al.  Induction of Neurasthenic Musculoskeletal Pain Syndrome by Selective Sleep Stage Deprivation , 1976, Psychosomatic medicine.

[20]  B. Danneskiold-Samsøe,et al.  Isometric and isokinetic muscle strength in patients with fibrositis syndrome. New characteristics for a difficult definable category of patients. , 1987, Scandinavian journal of rheumatology.

[21]  A. Bengtsson,et al.  Muscle tissue oxygen pressure in primary fibromyalgia. , 1986, Scandinavian journal of rheumatology.

[22]  M. Guazzelli,et al.  A polygraph evaluation of the effects of S-adenosyl-L-methionine (SAMe) on all-night sleep. , 1978, Monographien aus dem Gesamtgebiete der Psychiatrie.